Spots Global Cancer Trial Database for nilotinib+ad induction
Every month we try and update this database with for nilotinib+ad induction cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Nilotinib-Chemotherapy in CML Myeloid BP or Bcr-abl(+) AML | NCT01690065 | Chronic Myeloid... Untreated Adult... | Nilotinib+AD in... | 18 Years - 65 Years | Ulsan University Hospital |